Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Inventory Average (2024 - 2025)

Gyre Therapeutics (GYRE) has disclosed Inventory Average for 1 consecutive years, with $6.4 million as the latest value for Q4 2024.

  • On a quarterly basis, Inventory Average changed N/A to $6.4 million in Q4 2024 year-over-year; TTM through Dec 2024 was $6.4 million, a N/A change, with the full-year FY2024 number at $5.3 million, changed N/A from a year prior.
  • Inventory Average was $6.4 million for Q4 2024 at Gyre Therapeutics, up from $4.6 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $6.4 million in Q4 2024 to a low of $4.6 million in Q1 2024.